Welcome to LookChem.com Sign In|Join Free
  • or
N-[3-(1H-1,3-benzodiazol-2-yl)phenyl]-3-methoxybenzamide is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

420102-99-4

Post Buying Request

420102-99-4 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

420102-99-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 420102-99-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,2,0,1,0 and 2 respectively; the second part has 2 digits, 9 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 420102-99:
(8*4)+(7*2)+(6*0)+(5*1)+(4*0)+(3*2)+(2*9)+(1*9)=84
84 % 10 = 4
So 420102-99-4 is a valid CAS Registry Number.

420102-99-4Downstream Products

420102-99-4Relevant academic research and scientific papers

Benzimidazole derivative and application thereof

-

Paragraph 0011; 0022-0023; 0034, (2020/11/09)

The invention relates to the field of medicinal chemistry, in particular to a 3-(1H-benzo [d] imidazole-2-yl) aniline derivative with alpha-glucosidase inhibition activity, and the structural generalformula of the derivative is shown in the specification.

Design and synthesis of 2-arylbenzimidazoles and evaluation of their inhibitory effect against Chlamydia pneumoniae

Keurulainen, Leena,Salin, Olli,Siiskonen, Antti,Kern, Jan Marco,Alvesalo, Joni,Kiuru, Paula,Maass, Matthias,Yli-Kauhaluoma, Jari,Vuorela, Pia

supporting information; experimental part, p. 7664 - 7674 (2011/03/17)

Chlamydia pneumoniae is an intracellular bacterium that responds poorly to antibiotic treatment. Insufficient antibiotic usage leads to chronic infection, which is linked to disease processes of asthma, atherosclerosis, and Alzheimer's disease. The Chlamydia research lacks genetic tools exploited by other antimicrobial research, and thus other approaches to drug discovery must be applied. A set of 2-arylbenzimidazoles was designed based on our earlier findings, and 33 derivatives were synthesized. Derivatives were assayed against C. pneumoniae strain CWL-029 in an acute infection model using TR-FIA method at a concentration of 10 μM, and the effects of the derivatives on the host cell viability were evaluated at the same concentration. Fourteen compounds showed at least 80% inhibition, with only minor changes in host cell viability. Nine most potential compounds were evaluated using immunofluorescence microscopy on two different strains of C. pneumoniae CWL-029 and CV-6. The N-[3-(1H-benzimidazol-2-yl)phenyl]-3-methylbenzamide (42) had minimal inhibitory concentration (MIC) of 10 μM against CWL-029 and 6.3 μM against the clinical strain CV-6. This study shows the high antichlamydial potential of 2-arylbenzimidazoles, which also seem to have good characteristics for lead compounds.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 420102-99-4